Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer.
Saved in:
| Title: | Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer. |
|---|---|
| Authors: | Gao Y; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Li LX; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Rowland A; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Karapetis CS; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Parent N; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Kichenadasse G; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Hopkins AM; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia., Sorich MJ; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. Electronic address: michael.sorich@flinders.edu.au. |
| Source: | Cancer letters [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218191. Date of Electronic Publication: 2025 Dec 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41386504 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gao+Y%22">Gao Y</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Li+LX%22">Li LX</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Rowland+A%22">Rowland A</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Karapetis+CS%22">Karapetis CS</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Parent+N%22">Parent N</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Kichenadasse+G%22">Kichenadasse G</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Hopkins+AM%22">Hopkins AM</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Sorich+MJ%22">Sorich MJ</searchLink>; College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia. Electronic address: michael.sorich@flinders.edu.au. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600053%22">Cancer letters</searchLink> [Cancer Lett] 2026 Feb 28; Vol. 639, pp. 218191. <i>Date of Electronic Publication: </i>2025 Dec 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ireland%22">Elsevier Science Ireland </searchLink><i>Country of Publication: </i>Ireland <i>NLM ID: </i>7600053 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1872-7980 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203043835%22">03043835 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Lett <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41386504 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.canlet.2025.218191 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 218191 Titles: – TitleFull: Progressive lesion type is predictive of post-progression survival in first-line chemoimmunotherapy for Non-Small Cell Lung Cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gao Y – PersonEntity: Name: NameFull: Li LX – PersonEntity: Name: NameFull: Rowland A – PersonEntity: Name: NameFull: Karapetis CS – PersonEntity: Name: NameFull: Parent N – PersonEntity: Name: NameFull: Kichenadasse G – PersonEntity: Name: NameFull: Hopkins AM – PersonEntity: Name: NameFull: Sorich MJ IsPartOfRelationships: – BibEntity: Dates: – D: 28 M: 02 Text: 2026 Feb 28 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1872-7980 Numbering: – Type: volume Value: 639 Titles: – TitleFull: Cancer letters Type: main |
| ResultId | 1 |